Stock

Edgewise Therapeutics, Inc. EWTX

$40.60+3.39%

All stocks Create account to unlock

Overview

EWTX market data

Price History

EWTX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for EWTX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

10 captured

Evercore ISI Group Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $55 · Jul 20, 2026, 12:57 PM

8-K filing — Edgewise Therapeutics, Inc. (EWTX) · Jul 13, 2026, 12:37 PM

Oppenheimer Initiates Coverage On Edgewise Therapeutics with Outperform Rating, Announces Price Target of $51 · Jul 9, 2026, 1:40 PM

Guggenheim Maintains Buy on Edgewise Therapeutics, Raises Price Target to $51 · Jul 6, 2026, 2:10 PM

Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday · Jun 18, 2026, 2:35 PM

RBC Capital Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $59 · Jun 17, 2026, 3:05 PM

Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday · Jun 17, 2026, 1:10 PM

Goldman Sachs Maintains Neutral on Edgewise Therapeutics, Raises Price Target to $32 · Jun 17, 2026, 12:25 PM

Edgewise Therapeutics Reports Improvements In Heart Drug Trial · Jun 16, 2026, 5:40 PM

HC Wainwright & Co. Reiterates Buy on Edgewise Therapeutics, Maintains $45 Price Target · Jun 16, 2026, 4:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock